Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

10.63
Delayed Data
As of 2:40pm ET
 +0.265 / +2.56%
Today’s Change
8.70
Today|||52-Week Range
19.96
+15.49%
Year-to-Date
Cobalt Prices To Rocket As Tesla (TSLA) And Apple (AAPL) Scramble For Supplies
Apr 24 / Investing Channel - Paid Partner Content
The Surprising Reality of Option Trading in Morgan Stanley (MS)
Apr 19 / Investing Channel - Paid Partner Content
Using Tesla (TSLA) Stock Dynamics to Trade Options
Apr 20 / Investing Channel - Paid Partner Content
INSYS Therapeutics (INSY) - The Whos Who of The Marijuana Sector
Apr 19 / Investing Channel - Paid Partner Content
GW Pharmaceuticals (GWPH) - Cannabis Boom Creating a $30 Billion Investment Opportuni...
Apr 20 / Investing Channel - Paid Partner Content
Cannabis ETFs: joint venture
Mar 31 / FT.com - Paid Partner Content

Today’s Trading

Previous close10.36
Today’s open10.68
Day’s range10.37 - 10.68
Volume243,713
Average volume (3 months)967,068
Market cap$747.1M
Dividend yield--
Data as of 2:40pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)-87.01%
Earnings growth (this year)-121.05%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)-26.76%
P/E ratio106.3
Price/Sales2.82
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.55+3.44%
HSKAHeska Corp+1.10+1.03%
MGNXMacroGenics Inc+0.58+2.77%
DEPODepomed Inc+0.07+0.61%
Data as of 2:54pm ET, 04/25/2017

Financials

Next reporting dateJune 5, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$242.3M
Annual profit (last year)$7.6M
Net profit margin3.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Saeed Motahari
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts


Search for Jobs